Selecta Biosciences, a clinical-stage biopharmaceutical company based in Watertown, said today it has entered into a collaboration with Sanofi to develop three immunotherapy candidates for food allergies.
Under terms of the agreement, Selecta is eligible to receive several pre-clinical, regulatory and sales milestones totaling $300 million per allergen indication for up to three treatment candidates.
Selecta is also entitled to up to double-digit tiered royalties as percentage of net sales for each commercialized product.
Sanofi will also have access to Selecta's proprietary "Synthetic Vaccine Particle" platform.
Anda sedang membaca artikel tentang
Watertown biotech firm teams with Sanofi
Dengan url
http://emberemas.blogspot.com/2012/11/watertown-biotech-firm-teams-with-sanofi.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Watertown biotech firm teams with Sanofi
namun jangan lupa untuk meletakkan link
Watertown biotech firm teams with Sanofi
sebagai sumbernya
0 komentar:
Posting Komentar